ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 277 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $660,164 | +22.0% | 21,574 | +7.1% | 0.13% | +9.5% |
| Q3 2023 | $541,027 | -12.1% | 20,135 | +16.7% | 0.12% | -5.7% |
| Q2 2023 | $615,313 | +54.7% | 17,255 | +10.2% | 0.12% | +7.0% |
| Q1 2023 | $397,815 | -42.7% | 15,662 | -8.5% | 0.12% | -82.9% |
| Q4 2022 | $694,468 | +20.2% | 17,122 | -2.1% | 0.67% | +26.9% |
| Q3 2022 | $578,000 | -15.4% | 17,489 | -9.8% | 0.53% | +2.1% |
| Q2 2022 | $683,000 | -27.9% | 19,399 | -5.8% | 0.52% | +16.6% |
| Q1 2022 | $947,000 | -43.7% | 20,602 | -18.8% | 0.45% | -27.1% |
| Q4 2021 | $1,681,000 | – | 25,358 | – | 0.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
| Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
| M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
| WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
| Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
| Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
| JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
| COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
| Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
| Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |